{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:06:09Z","timestamp":1785852369063,"version":"3.56.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1097\/01.fjc.0000151899.03379.76","type":"journal-article","created":{"date-parts":[[2005,1,14]],"date-time":"2005-01-14T04:33:11Z","timestamp":1105677191000},"page":"125-135","source":"Crossref","is-referenced-by-count":32,"title":["In Vivo and In Vitro Antiarrhythmic Effects of SSR149744C in Animal Models of Atrial Fibrillation and Ventricular Arrhythmias"],"prefix":"10.1097","volume":"45","author":[{"given":"Patrick","family":"Gautier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Serre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Cosnier-Pucheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Djandjighian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Roccon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Nisato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00003495-199243010-00007","article-title":"Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.","volume":"43","author":"Gill","year":"1992","journal-title":"Drugs"},{"key":"R2-5-20210208","doi-asserted-by":"crossref","first-page":"3D","DOI":"10.1016\/S0002-9149(98)00147-7","article-title":"Antiarrhythmic drugs: re-orientation in light of recent developments in the control of disorders of rhythm.","volume":"81","author":"Singh","year":"1998","journal-title":"Am J Cardiol"},{"key":"R3-5-20210208","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1476-5381.1970.tb09892.x","article-title":"Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors.","volume":"39","author":"Charlier","year":"1970","journal-title":"Br J Pharmacol"},{"key":"R4-5-20210208","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-2952(76)90279-3","article-title":"The adrenergic antagonism of amiodarone.","volume":"25","author":"Polster","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"R5-5-20210208","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00584702","article-title":"Amiodarone blocks inactivated cardiac sodium channels.","volume":"396","author":"Mason","year":"1983","journal-title":"Pflugers Arch"},{"key":"R6-5-20210208","first-page":"650","article-title":"Amiodarone blocks calcium current in single guinea pig ventricular myocytes.","volume":"251","author":"Nishimura","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"R7-5-20210208","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0008-6363(97)00114-4","article-title":"Cellular electropharmacology of amiodarone.","volume":"35","author":"Kodama","year":"1997","journal-title":"Cardiovasc Res"},{"key":"R8-5-20210208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/j.1552-4604.1984.tb01822.x","article-title":"A classification of antiarrhythmic actions reassessed after a decade of new drugs.","volume":"24","author":"Vaughan Williams","year":"1984","journal-title":"J Clin Pharmacol"},{"key":"R9-5-20210208","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-122-9-199505010-00008","article-title":"Amiodarone: reevaluation of an old drug.","volume":"122","author":"Podrid","year":"1995","journal-title":"Ann Intern Med"},{"key":"R10-5-20210208","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00005344-200408000-00015","article-title":"In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic and anti-angiotensin II effects.","volume":"44","author":"Gautier","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"R11-5-20210208","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00005344-199509000-00016","article-title":"SR33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.","volume":"26","author":"Manning","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"R12-5-20210208","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0008-6363(97)00252-6","article-title":"Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties.","volume":"37","author":"Nattel","year":"1998","journal-title":"Cardiovasc Res"},{"key":"R13-5-20210208","first-page":"A4","article-title":"Hypokalemia as a simple reproducible model for sustained atrial fibrillation.","volume":"30","author":"Manoach","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"R14-5-20210208","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/01.RES.55.4.545","article-title":"Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol.","volume":"55","author":"Manning","year":"1984","journal-title":"Circ Res"},{"key":"R15-5-20210208","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.CIR.92.2.253","article-title":"Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats.","volume":"92","author":"Opitz","year":"1995","journal-title":"Circulation"},{"key":"R16-5-20210208","first-page":"53","article-title":"SSR149744C, a new antiarrhythmic drug, prevents experimental induced atrial fibrillation.","volume":"2","author":"Cosnier-Pucheu","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"R17-5-20210208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1476-5381.1984.tb10769.x","article-title":"An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents.","volume":"82","author":"Kane","year":"1984","journal-title":"Br J Pharmacol"},{"key":"R18-5-20210208","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cvr\/22.7.447","article-title":"The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion.","volume":"22","author":"Walker","year":"1988","journal-title":"Cardiovasc Res"},{"key":"R19-5-20210208","first-page":"167","article-title":"Protocole detude de lischemie aigue du myocarde chez le rat.","volume":"16","author":"Fabiani","year":"1977","journal-title":"Ann Chir Thorac Cardiovasc"},{"key":"R20-5-20210208","first-page":"73s","article-title":"Amiodarone and dronedarone reduce early mortality in post MI rats.","volume":"13","author":"Cosnier","year":"1999","journal-title":"Fund Clin Pharmacol"},{"key":"R21-5-20210208","first-page":"21","article-title":"Effects of amiodarone and dronedarone in the prevention of atrial arrhythmias in guinea pig isolated heart.","volume":"94","author":"Cosnier-Pucheu","year":"2001","journal-title":"Arch Mal Coeur Vaiss"},{"key":"R22-5-20210208","first-page":"A251","article-title":"Electrophysiological and anti-arrhythmic actions of a new amiodarone-like agent, dronedarone, in experimental atrial fibrillation.","volume":"30","author":"Finance","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"R23-5-20210208","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.90.4.2032","article-title":"Class III antiarhythmic drug action in experimental atrial fibrillation.","volume":"90","author":"Wang","year":"1994","journal-title":"Circulation"},{"key":"R24-5-20210208","first-page":"255","article-title":"Autonomic influence in the genesis of atrial arrhythmias: atrial flutter and fibrillation of vagal origin. In: Narula DS ed. Cardiac arrhythmias: electrophysiology, diagnosis and management.","volume":"243-","author":"Coumel","year":"1979","journal-title":"Baltimore: Williams Wilkins"},{"key":"R25-5-20210208","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/hh1101.091266","article-title":"Potential ionic mechanism for repolarization differences between canine right and left atrium.","volume":"88","author":"Li","year":"2001","journal-title":"Circ Res"},{"key":"R26-5-20210208","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.RES.0000096362.60730.AE","article-title":"Kv 1.5 is an important component of repolarizing K+ current in canine atrial myocytes.","volume":"93","author":"Fedida","year":"2003","journal-title":"Circ Res"},{"key":"R27-5-20210208","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.RES.72.1.75","article-title":"Rate-dependent prolongation of cardiac action potentials by a methanesulfonamide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide.","volume":"72","author":"Jurkiewicz","year":"1993","journal-title":"Circ Res"},{"key":"R28-5-20210208","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1046\/j.1540.8167.90302.x","article-title":"Mechanisms of termination of atrial fibrillation by class I antiarrhythmic drugs: evidence from clinical, experimental and mathematical modeling studies.","volume":"14","author":"Nattel","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R29-5-20210208","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00005344-199801000-00015","article-title":"Different effects of class Ic and III antiarrhythmic drugs on vagotonic atrial fibrillation in the canine heart.","volume":"31","author":"Hayashi","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"R30-5-20210208","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1472-8206.1993.tb00215.x","article-title":"Experimental models of torsades de pointes.","volume":"7","author":"Weissenburger","year":"1993","journal-title":"Fund Clin Pharmacol"},{"key":"R31-5-20210208","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(86)90336-0","article-title":"Hypokalemia and arrhythmias.","volume":"80","author":"Helfant","year":"1986","journal-title":"Am J Med"},{"issue":"Suppl","key":"R32-5-20210208","first-page":"15","article-title":"Hypokalemia-induced ultrastructural, histochemical and connexin-43 alterations resulting in atrial and ventricular fibrillations.","volume":"18","author":"Tribulova","year":"1999","journal-title":"Gen Physiol Biophys"},{"key":"R33-5-20210208","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005344-199606000-00005","article-title":"Effects of methylisobutyl amiloride on [Na+]i, reperfusion arrhythmias, and function in ischemic rat hearts.","volume":"27","author":"Tani","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"R34-5-20210208","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/00005344-199005000-00018","article-title":"Occlusion and reperfusion-induced arrhythmias in rats: involvement of platelets and effects of calcium antagonists.","volume":"15","author":"Sweies","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"R35-5-20210208","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(98)00878-4","article-title":"Ischemia\/reperfusion arrhythmias in anaesthetized rats: a role of Na+ and Ca2+ influx.","volume":"365","author":"Lu","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"R36-5-20210208","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3181\/00379727-212-43995","article-title":"Efficacy of the class III antiarrhythmic agent azimilide in rodent models of ventricular arrhythmia.","volume":"212","author":"Brooks","year":"1996","journal-title":"Proc Soc Exp Biol Med"},{"key":"R37-5-20210208","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1476-5381.1996.tb15762.x","article-title":"IK independent class III actions of MS-551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats.","volume":"119","author":"Chen","year":"1996","journal-title":"Br J Pharmacol"},{"key":"R38-5-20210208","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/sj.bjp.0705373","article-title":"Tedisamil and lidocaine enhance each others antiarrhythmic activity against ischemia-induced arrhythmias in rats.","volume":"139","author":"Sarraf","year":"2003","journal-title":"Br J Pharmacol"},{"key":"R39-5-20210208","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-2828(87)80585-0","article-title":"Models for the study of arrhythmias in myocardial ischemia and infarction: the use of the rat.","volume":"19","author":"Curtis","year":"1987","journal-title":"J Mol Cell Cardiol"},{"key":"R40-5-20210208","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/sj.bjp.0704509","article-title":"Independent contribution of catecholamines to arrythmogenesis during evolving infarction in the isolated rat heart.","volume":"135","author":"Clements-Jewery","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R41-5-20210208","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1540-8167.1997.tb00813.x","article-title":"Insights into mechanisms of antiarrhythmic drug action from experimental models of atrial fibrillation.","volume":"8","author":"Nattel","year":"1997","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R42-5-20210208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00003495-199243010-00007","article-title":"Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.","volume":"43","author":"Gill","year":"1992","journal-title":"Drugs"},{"key":"R43-5-20210208","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0008-6363(99)00232-1","article-title":"Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interaction with acute sotalol.","volume":"44","author":"Merot","year":"1999","journal-title":"Cardiovasc Res"},{"key":"R44-5-20210208","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.bjp.0704106","article-title":"Electrophysiological effects of dronedarone, a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone.","volume":"133","author":"Varro","year":"2001","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.fjc.0000151899.03379.76","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:42:06Z","timestamp":1785850926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200502000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fjc.0000151899.03379.76","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}